About
Chris co-founded Kronos Bio in 2017 and currently serves as COO. Additionally, he is an Operating Partner at Two River, where he has co-founded and held interim management roles in several Two River portfolio companies including Kite Pharma, Inc. (acquired by Gilead), Nile Therapeutics, Inc. (acquired by Capricor Therapeutics), and Neogene Therapeutics. Prior to Two River, Chris was a Director and led the US investment team at Trustbridge Partners, a healthcare and technology-focused growth equity firm based in China. Prior to that, he was a Consultant at Bain & Company. Chris received his Master of Business Administration from the MIT Sloan School of Management, and his Bachelor of Science in Economics from the Wharton School of the University of Pennsylvania.
Position in the VCSift Database
- • 10 investors hold the Chief Operating Officer and Co-Founder role in VCSift. Christopher Wilfong is one of them.
- • 2,293 investors are based in Boston, Massachusetts, United States.
Data sourced from 410,343 investor profiles. Updated July 2026.
Investment Focus
- Location
- Boston, US
Contact Information
Find more investors like Christopher
Search Investors